BELITE BIO INC - AMERICAN DEPOSITARY SHARES
45.50
05-July-24 13:28:28
15 minutes delayed
Stocks
-0.25
-0.55%
Today's range
44.91 - 45.77
ISIN
N/A
Source
NASDAQ
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 Aug 2023 22:17:28 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 Jul 2023 17:00:00 By Nasdaq GlobeNewswire
-
30 May 2023 20:49:26 By Nasdaq GlobeNewswire
-
30 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 May 2023 19:58:59 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 May 2023 15:33:22 By Nasdaq GlobeNewswire
-
04 May 2023 11:09:06 By Nasdaq GlobeNewswire
-
25 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2023 09:00:01 By Nasdaq GlobeNewswire
-
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
31 Mar 2023 19:03:37 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
31 Mar 2023 12:57:14 By Nasdaq GlobeNewswire
-
18 Nov 2022 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
01 Oct 2022 19:03:33 By Nasdaq GlobeNewswire
-
23 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 Sep 2022 08:00:32 By Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results
10 Aug 2022 21:51:10 By Nasdaq GlobeNewswire